Legault Pierre bought SNDX
February 4, 2026 · Form 4 insider transaction
Legault Pierre bought 24,000 shares of Syndax Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
24,000
Price
$0.00
Total value
N/A
InsiderLegault Pierre
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 4, 2026
Filing dateFebruary 6, 2026
Shares owned after114,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Award of Restricted Stock Units that vests one year from the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the earlier of a separation from service, death, disability or change in control.